“gilead-sciences” Archives

in
Entry Author Date Location
Bio Roundup: Obamacare Persists, FDA Approves, Vertex Wows & More 07/21/17 National
Bio Roundup: Trumpcare Is Mean, SCOTUS Says Go, Merck’s Myeloma No 06/16/17 National
UT Health Cancer Center Hires Rare Blood Cancer Expert as Director 06/15/17 Texas
Regulus Dumps Two Drugs, AstraZeneca Sends Back Another, Shares Fall 06/12/17 San Diego
Ex-Sarepta CEO Garabedian Returns to Run Bio Accelerator Xontogeny 05/18/17 Boston
Gates Foundation Leads $45.5M Round for Gerngross’s Biotech Arsanis 04/26/17 Boston
Cancer Drugmaker G1 Therapeutics Makes IPO Pitch To Wall Street 04/17/17 Raleigh Durham
Bio Roundup: Trump Backlash, Verdine Plans, Sarepta Sale & More 02/24/17 National
Bio Roundup: CRISPR Drama, Marathon and PhRMA, the Price of Vision & More 02/17/17 National
With $20M, UCSD Spinout Jecure To Press New Attack On NASH 02/15/17 San Diego
Bio Roundup: Travel Ban Block, Gilead Shock, Dean Kamen Talk & More 02/10/17 National
Bio Roundup: Tom Price, Patient Conflicts, Orphan Games & More 01/20/17 National
Vertex Deals Cancer Drugs to Merck KGaA for $230M, Following Plan 01/11/17 Boston
Bio Roundup: Trump’s Rx Silence, PCSK9 News, Amgen’s Migraines & More 11/18/16 National
Led by Former Lilly Exec, Apexian Out to Tackle Pancreatic Cancer 11/16/16 Indiana
Bio Roundup: Clinical Shirkers, AMD Worriers, ASH Fallers & More 11/04/16 National
Verastem Takes a Low-Cost Flier on Infinity’s Blood Cancer Drug 11/02/16 Boston
Bio Roundup: Jenkins Gets Mad, Bernie Gets His Pen, CRISPR IPO & J-Lo 10/21/16 National
After “Hubris” and Its HCV Collapse, Can Vertex Avoid Same Mistakes? 10/18/16 Boston
Early Data for Celgene’s Oral Crohn’s Drug Gets Mixed Reaction 10/17/16 New York
Bio Execs Talk Patient Advocacy, Duchenne Approval at BioForward Panel 09/28/16 Wisconsin
Bio Roundup: Mylan Grilled, Duchenne Kids Thrilled, Zuck-Chan & More 09/23/16 National
Pfizer Shells Out $14B to Win Medivation Sweepstakes 08/22/16 San Francisco
Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More 08/12/16 National
Biotech Roundup: Gilead Slump, Celgene Goes Trump, Hemo Data & More 07/29/16 National
Tobira Fails Main Goal in NASH Study, But Forges Ahead To Next Trial 07/25/16 San Francisco
Biotech Roundup: Fighting Addiction, Obama Precision, Juno Deaths & More 07/08/16 National
Biotech Roundup: Moonshots, Pink Slips, Gilead, Brexit & More 07/01/16 National
More Job Cuts at Infinity As AbbVie Sends Back Blood Cancer Drug 06/28/16 Boston
Regulus Shares Crumble As FDA Halts Testing of Hepatitis C Drug 06/27/16 San Diego
Page 1 of 9 next page »